BIOTECHNOLOGY New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China Medical Device News MagazineMay 28, 20250 Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025. Read More